Market Updates

NaPro Biotherapeutics, ChromaDex Form Agreement

Napro BioTherapeutics, Boulder, CO, has sold its technical and analytical services group to privately held Chroma­Dex, Inc., Santa Ana, CA, a supplier of phytochemical reference standards. Approximately 20 NaPro researchers will move to ChromaDex in the transaction along with specific physical and real estate assets. NaPro will become a significant shareholder of ChromaDex and will have a preferential business relationship with the company.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters